Endometrial cancer and its cell lines

  • 109 Accesses


Endometrial cancer is one of the most common gynaecological malignancies worldwide. One type of research in this field is the growing of cell lines (CLs) and cultures, which can be used to explore the biological mechanisms of cancer. The purpose of this review is to offer an overview of the current literature and highlight the importance of correct CL studies. We carried out a literature analysis of more than 60 articles from the Pubmed, Medline databases that were almost exclusively published in indexed journals in the last 10 years as well as the primary originating scientific studies of specific CLs. We then summarized the newest findings and recommendations. Cell lines are becoming widely used as in vitro tumour models. Recent work has shown inconsistencies in nomenclature and culturing of CLs. Their genomic evolution leads to a high degree of variation across CL strains therefore it is of the utmost importance to recognize the variability within laboratory cancer models. Laboratories must adapt, incorporate additional characterisation techniques and view this situation as an opportunity to improve the reproducibility of pre-clinical cancer research. The authors offer a comprehensive literature review about endometrial cancer CLs, a review of the current literature and advice on culturing CLs.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Fig. 1

Adapted from van Nyen et al. [14]

Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Adapted from Skok et al. [55]


  1. 1.

    Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29.

  2. 2.

    Tran A-Q, Gehrig P (2017) Recent advances in endometrial cancer. F1000Research 6:81.

  3. 3.

    Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30.

  4. 4.

    Zadnik V, Primic Zakelj M, Lokar K et al (2017) Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 51:47–55.

  5. 5.

    Society C (2016) Canadian cancer. Statistics (Ber) 2016:1–142

  6. 6.

    Lax SF (2016) Neues in der WHO-Klassifikation 2014 der Tumoren des Corpus uteri. Pathologe 37:500–511.

  7. 7.

    Talhouk A, McAlpine JN (2016) New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care. Gynecol Oncol Res Pract 3:14.

  8. 8.

    WHO (2014) Tumours of the uterine corpus. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of the female reproductive organs, 4th ed, pp 126–165

  9. 9.

    Lax SF (2019) Vorläuferläsionen der Endometriumkarzinome. Pathologe 40:13–20.

  10. 10.

    Bell DW, Ellenson LH (2019) Molecular genetics of endometrial carcinoma. Annu Rev Pathol Mech Dis 14:339–367.

  11. 11.

    Morice P, Leary A, Creutzberg C et al (2016) Endometrial cancer. Lancet 387:1094–1108.

  12. 12.

    Lax SF (2017) Pathology of endometrial carcinoma. In: Advances in experimental medicine and biology, pp 75–96

  13. 13.

    Ben-David U, Siranosian B, Ha G et al (2018) Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560:325–330.

  14. 14.

    Van Nyen T, Moiola CP, Colas E et al (2018) Modeling endometrial cancer: past, present, and future. Int J Mol Sci 19:2348.

  15. 15.

    Zhou X, Wang Z, Zhao Y et al (2007) Characterization of sixteen endometrial cancer cell lines. Cancer Res 67:3870

  16. 16.

    Kozak J, Wdowiak P, Maciejewski R, Torres A (2018) A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance. Cytotechnology 70:339–350.

  17. 17.

    Lin CY, Erkek S, Tong Y et al (2016) Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530:57–62.

  18. 18.

    Gasteiger E, Gattiker A, Hoogland C et al (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31:3784–3788.

  19. 19.

    Ghandi M, Huang FW, Jané-Valbuena J et al (2019) Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569:503–508.

  20. 20.

    Bairoch A (2018) The Cellosaurus, a cell-line knowledge resource. J Biomol Tech 29:25–38.

  21. 21.

    Dutil J, Chen Z, Monteiro AN et al (2019) An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines. Cancer Res 79:1263.

  22. 22.

    Korch C, Spillman MA, Jackson TA et al (2012) DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol 127:241–248.

  23. 23.

    Qu W, Zhao Y, Wang X et al (2019) Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. Clin Chim Acta 489:225–232

  24. 24.

    Hevir-Kene N, Rižner TL (2015) The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism. Chem Biol Interact 234:309–319

  25. 25.

    Nishida M, Kasahara K, Kaneko M et al (1985) Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nihon Sanka Fujinka Gakkai Zasshi 37:1103–1111

  26. 26.

    Nishida M (2002) The Ishikawa cells from birth to the present. Hum Cell 15:104–117

  27. 27.

    Kuramoto H (1972) Studies of the growth and cytogenetic properties of human endometrial adenocarcinoma in culture and its development into an established line. Acta Obstet Gynaecol Jpn 19:47–58

  28. 28.

    Fogh J (1986) Human tumor lines for cancer research. Cancer Investig 4:157–184.

  29. 29.

    Wang Y, Yang D, Cogdell D et al (2010) Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma. Technol Cancer Res Treat 9:179–189.

  30. 30.

    Dawe CJ, Banfield WG, Morgan WD et al (1964) Growth in continuous culture, and in hamsters, of cells from a neoplasm associated with acanthosis nigricans. JNCI J Natl Cancer Inst 33:441–456.

  31. 31.

    Satyaswaroop PG, Sivarajah A, Zaino RJ, Mortel R (1988) Hormonal control of growth of human endometrial carcinoma in nude mouse model. Prog cancer Res Ther 35:430–435

  32. 32.

    Ricci MS, Toscano DG, Toscano WA (1999) ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function. In Vitro Cell Dev Biol Animb 35:183–189.

  33. 33.

    Richardson GS, Dickersin GR, Atkins L et al (1984) KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol 17:213–230.

  34. 34.

    Rantanen V, Grénman S, Kulmala J et al (1994) Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay. J Cancer Res Clin Oncol 120:712–716.

  35. 35.

    Rantanen V, Grénman S, Kulmala J et al (1992) Radiation sensitivity of endometrial carcinoma in vitro. Gynecol Oncol 44:217–222.

  36. 36.

    Tate JG, Bamford S, Jubb HC et al (2018) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941–D947.

  37. 37.

    International Cell Line Authentication Committee (2015) Naming a cell line - ver. 1.6. Accessed 14 Apr 2018

  38. 38.

    Skok K, Gradišnik L, Čelešnik H et al (2019) Isolation and characterization of the first Slovenian human triple negative breast cancer cell line. Breast J.

  39. 39.

    Gradisnik L, Trapecar M, Rupnik MS, Velnar T (2015) HUIEC, Human intestinal epithelial cell line with differentiated properties: process of isolation and characterisation. Wien Klin Wochenschr 127:204–209.

  40. 40.

    Naranda J, Gradišnik L, Gorenjak M et al (2017) Isolation and characterization of human articular chondrocytes from surgical waste after total knee arthroplasty (TKA). PeerJ 5:e3079.

  41. 41.

    Geraghty RJ, Capes-Davis A, Davis JM et al (2014) Guidelines for the use of cell lines in biomedical research. Br J Cancer 111:1021–1046.

  42. 42.

    Howe B, Umrigar A, Tsien F (2014) Chromosome preparation from cultured cells. J Vis Exp.

  43. 43.

    Lee C-Y, Lee Y-F, Chuang EY et al (2018) Cell Express: a comprehensive microarray-based cancer cell line and clinical sample gene expression analysis online system. Database.

  44. 44.

    Burry RW (2011) Controls for immunocytochemistry: an update. J Histochem Cytochem 59:6–12.

  45. 45.

    Poojan S, Kim H-S, Yoon J-W et al (2018) Determination of protein expression level in cultured cells by immunocytochemistry on paraffin-embedded cell blocks. J Vis Exp.

  46. 46.

    Ferreira-Silva B, Fonseca-Cardoso M, Porto MJ et al (2018) A comparison among three multiplex Y-STR profiling kits for sexual assault cases. J Forensic Sci 63:1836–1840.

  47. 47.

    Crawford MH, Beaty KG (2013) DNA fingerprinting in anthropological genetics: past, present, future. Investig Genet 4:23.

  48. 48.

    Hynds RE, Vladimirou E, Janes SM (2018) The secret lives of cancer cell lines. Dis Model Mech 11:dmm037366.

  49. 49.

    Lai ZW, Bolm L, Fuellgraf H et al (2016) Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses. BMC Cancer 16:195.

  50. 50.

    Fusenig NE, Capes-Davis A, Bianchini F et al (2017) The need for a worldwide consensus for cell line authentication: experience implementing a mandatory requirement at the International Journal of Cancer. PLoS Biol 15:e2001438

  51. 51.

    Lorsch JR, Collins FS, Lippincott-Schwartz J (2014) Fixing problems with cell lines. Science 346:1452.

  52. 52.

    Shah RN, Grzybowski AT, Cornett EM et al (2018) Examining the roles of H3K4 methylation states with systematically characterized antibodies. Mol Cell 72:162.

  53. 53.

    Loken E, Gelman A (2017) Measurement error and the replication crisis. Science 355:584.

  54. 54.

    Weissgerber TL, Savic M, Winham SJ et al (2017) Data visualization, bar naked: a free tool for creating interactive graphics. J Biol Chem 292:20592–20598.

  55. 55.

    Skok K, Takač I, Kavalar R et al (2019) Simple protocol for effective preparation of breast cancer cell cultures for possible 3D tumor modeling. EPNOE Newletter 7–8

  56. 56.

    Skok K, Maver U, Gradišnik L et al (2019) Human breast cancer cell lines. Slov Med J.

  57. 57.

    Kuramoto H, Nishida M, Morisawa T et al (1991) Establishment and characterization of human endometrial cancer cell lines. Ann N Y Acad Sci 622:402–421.

  58. 58.

    Yu M, Selvaraj SK, Liang-Chu MMY et al (2015) A resource for cell line authentication, annotation and quality control. Nature 520:307–311.

  59. 59.

    Mosoyan G, Nagi C, Marukian S et al (2013) Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential. PLoS ONE 8:e55145.

  60. 60.

    Lacroix M, Haibe-Kains B, Hennuy B et al (2004) Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes. Oncol Rep 12:701–707

  61. 61.

    Hiscox S, Baruha B, Smith C et al (2012) Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12:458.

  62. 62.

    Kasai F, Hirayama N, Ozawa M et al (2016) Changes of heterogeneous cell populations in the Ishikawa cell line during long-term culture: proposal for an in vitro clonal evolution model of tumor cells. Genomics 107:259–266.

  63. 63.

    Li W, Wang S, Qiu C et al (2019) Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line. J Transl Med 17:58.

  64. 64.

    Pickl M, Ries CH (2009) Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 28:461–468.

  65. 65.

    Gillet J-P, Varma S, Gottesman MM (2013) The clinical relevance of cancer cell lines. J Natl Cancer Inst 105:452–458.

  66. 66.

    Wilding JL, Bodmer WF (2014) Cancer cell lines for drug discovery and development. Cancer Res 74:2377–2384.

  67. 67.

    Galuschka C, Proynova R, Roth B et al (2017) Models in translational oncology: a public resource database for preclinical cancer research. Cancer Res 77:2557–2563.

Download references

Author information

KS, UM, LG, NK, DA and IT designed the study. KS, UM, LG, NK, DA and IT wrote the manuscript and prepared the figures. All authors reviewed the manuscript.

Correspondence to Kristijan Skok or Darja Arko.

Ethics declarations

Conflict of interest

The authors have no conflict of interests for this article.

Ethical approval


Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Skok, K., Maver, U., Gradišnik, L. et al. Endometrial cancer and its cell lines. Mol Biol Rep 47, 1399–1411 (2020).

Download citation


  • Endometrial cancer
  • Cell line
  • Tissue culture
  • Cancer cell line
  • In vitro models
  • Cell isolation